Oct 2026· Frontiers in Neurology· Vol 17· 0 citations· 40 references
Medicine
TL;DR
Significant unexplained heterogeneity, low-to-very-low certainty of evidence, and the exclusively Chinese evidence base warrant cautious interpretation and limit generalizability.
Abstract
Objective To evaluate the effects of adjunctive hyperbaric oxygen therapy (HBOT) on cognitive, neurological, and functional outcomes in patients with post-stroke cognitive impairment (PSCI), and explore potential sources of heterogeneity. Methods Eight databases were searched from inception to July 15, 2026. Randomized controlled trials (RCTs) evaluating adjunctive HBOT in patients with PSCI were included. The primary outcome was the Montreal Cognitive Assessment (MoCA); secondary outcomes included the Mini-Mental State Examination (MMSE), National Institutes of Health Stroke Scale (NIHSS), Modified Barthel Index (MBI), and Barthel Index (BI). Random-effects meta-analyses, prespecified subgroup analyses, and meta-regression were performed. Sensitivity analyses, funnel plots, Egger’s tests, and GRADE assessments were conducted. Results Thirty-five RCTs involving 3,036 participants, all conducted in China, were included. Adjunctive HBOT was associated with higher MoCA scores (MD = 2.90, 95% CI: 2.47–3.33; p < 0.00001; I2 = 84%) and MMSE scores (MD = 2.68, 95% CI: 2.20–3.16; p < 0.00001; I2 = 83%). Improvements were also observed in NIHSS (MD = −2.61, 95% CI: −3.34 to −1.89; p < 0.00001; I2 = 93%), MBI (MD = 6.64, 95% CI: 3.76–9.52; p < 0.00001; I2 = 82%), and BI (MD = 8.77, 95% CI: 4.72–12.82;p < 0.00001; I2 = 82%). No statistically significant subgroup differences were observed for MoCA (p = 0.10) or MMSE (p = 0.43). Higher baseline MoCA scores tended to be associated with smaller treatment effects in meta-regression (β = −0.1411, p = 0.0637; R2 = 15.42%). Substantial heterogeneity remained largely unexplained. Evidence certainty was low for MoCA, MMSE, and MBI and very low for NIHSS and BI. Conclusion Adjunctive HBOT may provide cognitive and functional benefits in patients with PSCI. However, substantial unexplained heterogeneity, low-to-very-low certainty of evidence, and the exclusively Chinese evidence base warrant cautious interpretation and limit generalizability. Further well-designed RCTs involving diverse populations are needed. Systematic review registration https://www.crd.york.ac.uk/PROSPERO/view/CRD420261473579, PROSPERO, CRD420261473579.
HBOT may improve cognitive performance in both healthy and clinical older adults and may offer modest benefits for physical performance, although physical improvements were sometimes inferred from functional or indirect measures.
M. Mohammadi, Amin Norouzi Fashkhami, A. Baghban· Journal of Aging and Physica...· 0 citations
Adjunctive HBO may improve swallowing function and related outcomes in PSD, but the clinical certainty is limited by methodological weaknesses, heterogeneity, incomplete reporting of intervention parameters, and insufficient TSA information size for several patient-centered outcomes.
Xiao-Guang Lin, Lin-Jing Wang, Min-Min Wu et al.· European Journal of Medical...· 0 citations
Background Oxiracetam is used in China for cognitive dysfunction after traumatic brain injury (TBI), but its efficacy and safety remain uncertain. We assessed oxiracetam in adults with acute TBI. Methods We searched six bibliographic databases and trial registries from inception through 28 February 2026, for randomized...
Mi-Mi Wang, Ning Cao, Zhang-Xuan Shou et al.· Frontiers in Pharmacology· 0 citations
Hyperbaric oxygen therapy (HBOT) has been proposed as an adjunctive treatment in acute myocardial infarction (AMI) due to its potential to enhance oxygen delivery and attenuate ischemia–reperfusion injury. However, its clinical benefit in the era of modern reperfusion therapy remains uncertain.
A systemati...
K. Zenjaya, Leoni, L. Handoko et al.· European Heart Journal, Supp...· 0 citations
OBJECTIVE
To evaluate the efficacy of choline alfoscerate in mild cognitive impairment through a meta-analysis of randomized clinical trials considering potential sources of bias.
MATERIAL AND METHODS
A systematic search and meta-analysis were conducted, including three randomized controlled trials of choline alfosce...
A. Shmonin, I. Kashaev, G. S. Bakulin et al.· Zhurnal Nevrologii i Psikhia...· 0 citations
It is suggested that minocycline is biologically credible, but it did not demonstrate a consistent benefit in functional or neurological outcomes after AIS, and minocycline is viewed as a promising adjunct that now needs better targeted, biomarker-informed, reperfusion-aware trials rather than immediate universal use i...
M. Altaha, A. Abobaker, Muath Almuhanna et al.· The Egyptian Journal of Neur...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.